Is there a biological basis for geriatric pharmacotherapy?

Area of Science:

• Gerontology
• Pharmacology
• Biomedical Research

Background:

• Geriatric pharmacotherapy development faces challenges.
• Integration of biological, clinical, and pharmacological knowledge is crucial.
• Applied gerontology often overlooks basic experimental gerontology due to perceived theoretical nature.

Purpose of the Study:

• To discuss the development of geriatric pharmacotherapy.
• To highlight the importance of interdisciplinary research.
• To demonstrate the applicability of recent biological aging research to pharmacotherapy.

Main Methods:

• Literature review and synthesis of current research.
• Analysis of recent findings in biological aging.
• Conceptualization of pharmacotherapy based on aging mechanisms.

Main Results:

• Biological aging research, especially concerning skeletal muscle and central nervous system (CNS) aging, has yielded significant new knowledge.
• This knowledge has direct implications for developing specific geriatric pharmacotherapies.
• Bridging basic research and clinical application is feasible and beneficial.

Conclusions:

• A specific geriatric pharmacotherapy can be developed by integrating basic biological aging research with clinical and pharmacological data.
• Advances in understanding skeletal muscle and CNS aging provide a foundation for novel therapeutic strategies.
• Interdisciplinary collaboration is essential for advancing geriatric medicine.